ISSN: 1567-2050
Journal Home
Journal Guideline
Current Alzheimer Research Q3 Unclaimed
Current Alzheimer Research is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 103. It has an SJR impact factor of 0,584 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,584.
Current Alzheimer Research focuses its scope in these topics and keywords: alzheimers, role, disease, fluid, failure, efficiency, earliest, diseasethe, diseasesemantic, diseaselipid, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,584
SJR Impact factor103
H Index60
Total Docs (Last Year)306
Total Docs (3 years)3843
Total Refs659
Total Cites (3 years)294
Citable Docs (3 years)1.8
Cites/Doc (2 years)64.05
Ref/DocOther journals with similar parameters
CNS oncology Q3
Neurology: Clinical Practice Q3
Restorative Neurology and Neuroscience Q3
Translational Medicine of Aging Q3
Stroke Research and Treatment Q3
Compare this journals
Aims and Scope
Best articles by citations
Elevated Aβ42 in Aged, Non-demented Individuals with Cerebral Atherosclerosis
View moreIntra and Extracellular Protein Interactions with Tau
View moreMechanism of Tau-Induced Neurodegeneration in Alzheimer Disease and Related Tauopathies
View moreInvolvement of Rat Hippocampal Astrocytes in β-Amyloid-Induced Angiogenesis and Neuroinflammation
View morePlanum Temporale Analysis Via a New Volumetric Method in Autoptic Brains of Demented and Psychotic Patients
View moreInhibition of Tau Protein Aggregation by Rhodanine-based Compounds Solubilized Via Specific Formulation Additives to Improve Bioavailability and Cell Viability
View moreEditorial (Thematic Issue: From Current Diagnostic Tools and Therapeutics for Alzheimer's Disease Towards Earlier Diagnostic Markers and Treatment Targets)
View moreDietary Omega 3 Polyunsaturated Fatty Acids and Alzheimers Disease: Interaction with Apolipoprotein E Genotype
View moreVisualization of Brain Amyloid and Microglial Activation in Mouse Models of Alzheimers Disease
View moreSocial Determinants, Race, and Brain Health Outcomes: Findings from the Chicago Health and Aging Project
View moreDisease State, Age, Sex, and Post-Mortem Time-Dependent Expression of Proteins in AD vs. Control Frontal Cortex Brain Samples
View moreLack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease
View moreTubulin-Independent Tau in Alzheimers Disease and Cancer: Implications for Disease Pathogenesis and Treatment
View moreTargeting Post-Translational Remodeling of Ryanodine Receptor: a New Track for Alzheimer's Disease Therapy?
View moreEditorial (Thematic Issue: Prevention Strategies Targeting Different Preclinical Stages of Alzheimer's Disease)
View moreLong Term Caregiving: Helping Families of Persons with Mild Cognitive Impairment Cope
View moreIL-3 Control Tau Modifications and Protects Cortical Neurons from Neurodegeneration
View moreMeet Our Editorial Board Member
View moreMeet our Editorial Board Member
View moreMetabotropic Glutamate Receptor 5 in Down's Syndrome Hippocampus During Development: Increased Expression in Astrocytes
View moreWhat Metabolic Syndrome Contributes to Brain Outcomes in African American & Caucasian Cohorts
View moreRole of APP and Aβ in Synaptic Physiology
View moreOligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form
View moreBrain MRI, Apoliprotein E Genotype, and Plasma Homocysteine in American Indian Alzheimer Disease Patients and Indian Controls
View more
Comments